NCT00734786

Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles

Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles. Study # CLN 08-003.

• Status: Withdrawn
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: Phytotox SA · Industry
• Sex: Female
• Age: 30 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The main objective of the trial is to determine whether the current topical formulation of GTX 2/3 reduces the wrinkling of the skin (crow's feet) after a single application Other evaluation criteria include: safety assessment and local tolerance, depth of facial wrinkles (video microscopy imaging).

Detailed description

This is a single volunteer group study. Each volunteer will be her own control. A volunteer will receive the active product containing cream on one side of her face and will receive the placebo cream on the other side.

Conditions

• Facial Wrinkles

Interventions

Type	Name	Description
OTHER	Wrinkle cream application	Single application on the crow's feet wrinkles. Placebo cream will be applied on one side, the active cream on the other side.

Timeline

• Start date: 2008-08-01
• Primary completion: 2008-09-01
• Completion: 2008-09-01
• First posted: 2008-08-14
• Last updated: 2008-08-25

Locations

1 site across 1 country: Argentina